N
NAUT
Nautilus Biotechnology Inc
3.120
-0.230-6.87%After Hours: 3.210 +0.090 +2.88%19:48 04/07 EDT
OPEN/PREV CLOSE3.290/3.350
TODAY RANGE3.050-3.365
VOL404.63K
MARKET CAP394.88M
52 WEEK RANGE0.6200-4.310
AVG VOL (3M)280.20K
% TURNOVER0.32%
TURNOVER--
P/E (TTM)-6.6767
% RANGE9.40%
EPS(TTM)-0.4673
P/E(FORWARD)-5.6727
P/B2.514
BVPS1.241
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP222.74M
SHARES OUTSTANDING126.56M
NEXT EARNINGS04/27-05/01
FREE FLOAT71.39M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/18 12:11
Nautilus announces first customer of its Iterative Mapping Early Access Program
TipRanks·03/05 02:15
Top Nautilus Biotechnolgy Insider Quietly Boosts His Stake in a Big Way
Reuters·03/04 23:37
Nautilus Biotechnology CEO Sujal M Patel Acquires Common Shares
TipRanks·03/02 13:31
Nautilus Biotechnology appoints Faust as Vice President of Sales
Reuters·03/02 13:03
Nautilus Biotechnology names Amber Faust vice president of sales
Dow Jones·02/27 15:52
Nautilus Biotechnology Price Target Raised to $4.00/Share From $2.50 by Guggenheim
Dow Jones·02/27 15:52
Nautilus Biotechnology Is Maintained at Buy by Guggenheim
Benzinga·02/27 15:41
Guggenheim Maintains Buy on Nautilus Biotechnology, Raises Price Target to $4
TipRanks·02/27 12:36
Nautilus Biotechnology price target raised to $4 from $2.50 at Guggenheim
TipRanks·02/27 00:24
Nautilus Biotechnolgy Charts Cash-Backed Path to 2027
Same Industry
Name/Symbol
Change%
Price